Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Deuterated water (D2O), also known as heavy water, is a stable isotope tracer used in clinical research to quantify metabolic flux. In the context of studies conducted by Columbia University, it is administered to patients with non-alcoholic fatty liver disease (NAFLD), insulin resistance, and hyperinsulinemia to measure hepatic de novo lipogenesis (DNL). By tracking the incorporation of deuterium into newly synthesized triglycerides or glucose, researchers can assess the rate of these metabolic pathways. This diagnostic tool is essential for understanding the pathogenesis of NAFLD and evaluating how therapeutic interventions, such as diazoxide, affect the liver's handling of fat and sugar.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on deuterated water.